A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction. (Q45209475)

From Wikidata
Jump to navigation Jump to search
scientific article published in January 2005
  • A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction
edit
Language Label Description Also known as
English
A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction.
scientific article published in January 2005
  • A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction

Statements

title
A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15629368
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15629368%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 January 2020
author

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q45209475&oldid=1834092769"